Abstract #4659

Targeting metabolism to interrogate immunotherapy resistance in melanoma and predicting therapy efficacy employing HP-MRSI

Shivanand Pudakalakatti¹, Grace A Murley², William Padron², Jorge Delacerda², Aldo Rodriguez Morales², Muxin Wang², Renee L Chin², William F Schuler², Jose S Enriquez², Kunal Rai³, Mark D Pagel⁴, and Pratip Bhattacharya²

¹Cancer Systems Imaging, University of Texas MD Anderson Cancer Center, Houston, TX, United States, ²University of Texas MD Anderson Cancer Center, Houston, TX, United States, ³Genomics Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States, ⁴Medical Physics, University of Wisconsin, Madison, WI, United States

Synopsis

Keywords: Hyperpolarized MR (Non-Gas), Hyperpolarized MR (Non-Gas), Melanoma, Sensitizing immunotherapy

Motivation: Sensitizing immunotherapy resistant melanoma and interrogating the efficacy of combination treatment at an early stage of treatment resistance can provide physicians with sufficient time to adjust treatment plans and increase survival.

Goal(s): Enhancing the sensitivity of immune checkpoint blockade (ICB)-resistant melanoma to immunotherapy by targeting metabolism-related proteins and assessment of treatment efficacy.

Approach: Established ICB-resistant B16-F4 melanoma mice were divided into three groups: 1) ICB and monocarboxylate transporter (MCT) inhibitor, 2) ICB, and 3) PBS-treated controls, to assess survival benefits and early efficacy using HP-MRSI.

Results: Preliminary HP-MRSI data shows early efficacy of combination therapy of MCT inhibitor and ICB.

Impact: The research demonstrates an innovative image-driven pathway to sensitize immunotherapy-resistant melanoma in a preclinical setting. We have shown early efficacy, reduced tumor growth, and improved survival in mice treated with an MCT inhibitor and ICB and interrogated these using HP-MRSI.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.